Somatic mutations of the isocitrate dehydrogenase 1 and 2 genes (IDH1 and IDH2) are frequent and early events in the pathogenesis of low-grade gliomas as well as in a small subset of GBMs [4, 5]. This evidence concerns the gene IDH1 and low grade glioma.